Thalocan Research Innovations Lesion Area Mapping Assistant (LAMA) was a HIT at the American Academy of Dermatology 2026 Annual meeting in Denver this past weekend. Many thanks to our COO, Cyrus Mirakhor for running such seamless and informative demonstrations. The Lesion Area Mapping Assistant is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical trials.

Investigators can securely capture clinical images, map lesions, and document severity assessments using their own device or a study-provided tablet. LAMA enables real-time data sharing among investigators, CROs, and sponsors, with time-lapse review of treatment responses.

Features include precise lesion mapping, standardized notations, and measurement tools to improve accuracy and data quality. To learn more about LAMA and see an online demonstration, visit https://hubs.ly/Q049y_Z80